Preprint
Article

This version is not peer-reviewed.

Prevalence of Obstructive Sleep Apnea (OSA) Symptoms in the Workplace and Their Association with Metabolic and Mental Health Problems and Injuries: A Cross-Sectional Study

Submitted:

02 November 2026

Posted:

04 November 2026

You are already at the latest version

Abstract
Obstructive sleep apnea (OSA) is a common and underdiagnosed condition that has a significant impact on health and safety. Because it is not an occupational disease, it is not systematically screened for in the workplace. We conducted a census on 2,226 workers from various productive sectors to evaluate the frequency of suspected OSA, using the Berlin questionnaire, and studied the association with metabolic and mental health problems and injuries. This revealed a prevalence of high risk of OSA of 15.6% (95%CI=14.1;17.2). Workers with suspected OSA had worse sleep quality, greater sleepiness, and greater perceived stress than other asymptomatic workers. They had a higher prevalence of hypertension, dyslipidemia, obesity, hyperglycemia, metabolic syndrome, and higher levels of mental health problems. They also had more frequent home- and work-related injuries. The risk that workers may suffer from OSA should be systematically investigated in the workplace.
Keywords: 
;  ;  ;  ;  ;  ;  ;  ;  

1. Introduction

Obstructive sleep apnea (OSA) is a common, yet highly underdiagnosed, disease. This sleep disorder is marked by recurrent episodes of upper airway collapse, either full (apnea) or partial (hypopnea) [1], which results in oxygen desaturation or sleep arousal [2]. Frequent interruptions cause sleep to be fragmented and non-restorative. Loud, disturbing snoring, observed apneas, and excessive daytime sleepiness are among the symptoms. Although very common, these symptoms do not alarm patients and do not prompt them to report them immediately to their doctor [3]; women are more prone to underreporting snoring [4]. Doctors, for their part, do not always systematically investigate sleep [5,6]. Cardiovascular [7,8,9,10,11,12,13], cognitive [14,15] and mental health [16,17], the quality of life [18,19,20], and driving safety [21,22] are all significantly impacted by this illness. Home sleep apnea tests [23] or polysomnography [24,25] are used in the diagnosis process. Oral appliances, surgery, and continuous positive airway pressure (CPAP) therapy are available as forms of nonpharmacologic treatment [26,27].
The prevalence of OSA is high. According to current estimates, about 1 billion individuals worldwide have five or more apneic episodes per hour [28], while there are thought to be 425 million working-age adults between 30 and 69 years with moderate or severe OSA (15 or more events per hour) [29]. Meta-analyses estimate a worldwide pooled prevalence of 54% in the general population [30]. In Europe, 18% of the population is affected [31]. The growing incidence of OSA correlates with escalating levels of obesity [32,33], as well as with the aging population and workforce [34]. In Italy it is estimated that there are over 4.5 million people who need treatment, but only 280,000 are treated with CPAP and a few thousand with other methods [35]. An estimated 80%-85% of moderate to severe sleep apnea cases remain undiagnosed [36,37,38] and little is done to increase diagnoses, even though the treatment of OSA is definitely cost-effective [39]. For untreated adults, OSA results in 2.5 times higher healthcare costs compared to non-OSA individuals [40]. Moreover, treating OSA cases is cost-effective from the perspective of tax-funded healthcare systems [41,42].
Although there is consensus on the high frequency of the syndrome and its importance for health and safety, very few studies have evaluated the phenomenon in the workplace. As OSA is not an occupational risk, it is not routinely monitored. However, undiagnosed OSA can have serious consequences in the workplace, and this justifies screening especially in work sectors with a high risk of accidents [43]. Because the disease has a significant impact on working ability [44], reduces occupational productivity [45,46], and increases the risk of accidents at work [47,48,49,50], screening could be beneficial for both individuals and companies.
Because of these considerations, we decided to evaluate the frequency of symptoms compatible with OSA in all workers undergoing health surveillance in the small companies monitored by our occupational medicine unit. We also aimed to evaluate the association between suspected OSA and the physical and mental health of workers.

2. Materials and Methods

2.1. Population

During the mandatory periodic check-up conducted at the workplace of the small companies that request health surveillance services from our university, all the employees were invited to participate in an annual health promotion campaign focused on the risk of obstructive sleep apnea. The law allows health promotion activities to be included in the mandatory check-ups required for those exposed to occupational risks. This strategy, known in the US as Total Worker Health (TWH©) [51] and in Italy as Promotion in Prevention (PIP) [52], is generally well received by workers and achieves high participation rates [53].
Participation was free, voluntary, and independent of the fitness assessment. Participants were asked to complete a questionnaire. Subsequent consultations enabled the physician to review the responses and, where necessary, recommend seeking care through National Health Service facilities to confirm the diagnosis and undergo treatment.
A total of 2,231 out of the 2,297 workers (97.1%) participated. None of them were professionally exposed to chemical risks such as phthalate [54], polycyclic aromatic hydrocarbons [55], ethylene oxide [56], brominated flame retardants [57] or secondhand smoke [58] that could contribute to OSA. The sample did not include professional drivers or construction workers, who are included among the professions at high risk for the potential consequences of OSA, or workers performing more than 80 night shifts per year (night workers) who might have a slight, if not negligible, association with OSA [59]. Five of the participants had a diagnosis of OSA and were undergoing CPAP treatment. These workers were excluded from the analyses presented in this article. The sample thus consisted of 2,226 individuals.
The study was conducted in accordance with the Declaration of Helsinki. The research was approved by the Ethics Committee of the Università Cattolica del Sacro Cuore, Policlinico Gemelli Foundation, in Rome (protocol No. 1226 24/11/2016). Participation was voluntary, and all data were collected anonymously and handled confidentially. Signed informed consent was obtained from all participants prior to participation. The participants were informed that data obtained from health surveillance would be disclosed in anonymous form to company management and the company's prevention and protection service and might be published; they accepted this by signing their respective health records. Data collected during the study have been deposited in a publicly available repository (DOI 10.5281/zenodo.23770854). The authors declare that they have no competing interests, financial or otherwise, that could have influenced the work reported in this paper. No generative artificial intelligence (GenAI) has been used in this paper.

2.2. Questionnaires

The risk of OSA was assessed using the Berlin questionnaire (BQ) [60]. The standard BQ is a 10-item screening tool divided into three categories that evaluate snoring behavior, wake-time sleepiness/fatigue, and history of obesity/hypertension in order to stratify patients into high-risk or low-risk groups for OSA. Those who test positive in at least two categories are considered high-risk patients (HRO). In this study the questionnaire had a Cronbach’s value of 0.717.
Sleep quality was assessed using the Italian version [61] of the Pittsburgh Sleep Quality Index (PSQI) [62]. This instrument consists of 18 questions organized into 5 components. A total score greater than 5 is considered indicative of poor sleep quality. The reliability of the questionnaire in this study was 0.836.
Sleepiness was assessed using the Italian version [63] of the Epworth Sleepiness Scale (ESS) [64]. This instrument consists of 8 items regarding the likelihood of falling asleep in various situations. Responses are rated on a 4-point Likert scale, ranging from 0 to 3. The author indicated that a score above 10 is indicative of excessive daytime sleepiness. We adopted this cut-off level, although some researchers have stated that it is not always clinically useful [65] and have proposed different values [66]. The questionnaire had a reliability of 0.759 in this study.
Work annoyance, i.e. the level of annoyance that workers feel about certain aspects of the job, was measured with the nine-item self-reported measure that asks participants to rate the level of annoyance that they feel (or would feel) about certain characteristics of their work activity on an 11-point, Likert-type intensity scale (ranging from 0 = No annoyance to 10 = Utmost annoyance) [67]. The scale had a reliability of 0.812 in this study.
Work-related stress was assessed using the Italian short-form version [68] of Siegrist’s Effort-Reward Imbalance (ERI) model [69]. This instrument consists of 10 items rated on a 4-point Likert scale: the first three measure work-related effort (final score ranging from 3 to 12), while the remaining seven measure the material or non-material rewards received for the work (total score ranging from 7 to 28). Stress (ERI) is measured by the weighted ratio of these two variables. A score greater than 1 indicates a state of emotional distress. Cronbach’ alpha was 0.799 for effort, 0.721 for reward.
Overcommitment was measured using the scale of the same name from the Siegrist’s model [69], consisting of six items rated on a 4-point Likert scale. Scores range from 6 to 24. The reliability was 0.765 in this research.
Social support [70] was measured using the corresponding scale from the Italian version [71] of Karasek’s questionnaire [72]. The scale consists of 6 questions with responses rated from 1 to 4. The resulting score ranges from 6 to 24; higher scores indicate greater support from colleagues and superiors. In this study the reliability of the questionnaire, measured by Cronbach’s alpha, was 0.833.
Job satisfaction was measured using the final question of the Italian version [73] of the Warr et al. questionnaire [74], with responses rated on a 7-point Likert scale ranging from “extremely dissatisfied” (=1) to “extremely satisfied” (=7).
To measure work ability, we used the Italian version [75] of the 1st item of the Work Ability Index (WAI) [76], which consists of a single question comparing current work ability with one's lifetime best. The response, rated on an 11-point scale from 0 to 10, shows a strong correlation with the full questionnaire [77].
Mental distress was assessed using Goldberg’s General Health Questionnaire, 12-item version (GHQ-12), rated on a 4-point Likert scale ranging from 0 to 3 [78,79,80]. Scores above 11 are considered indicative of anxiety, depression, or other potential mental disorders [81,82]. The reliability of the questionnaire was 0.892 in this study.
Happiness was measured using the Abdel-Khalek questionnaire (AKQ) [83], a single, 0–10 graded question.
Lifestyle habits were assessed using single questions with 4-point Likert scales regarding smoking habits (from 1 = never smoked to 4 = every day), frequency of leisure-time physical activity (from 1 = three or more times a week to 4 = never), control of salt, sugar, or fat intake in meals (from 1 = in every meal to 4 = never), and alcohol consumption (from 1 = none to 4 = more than 16 units per week).
Immediately after completing the questionnaire, the workers underwent a periodic medical examination, during which it was possible to further investigate the problems reported in the questionnaire. Their blood pressure was measured, and anthropometric measurements (height, weight, and waist circumference) were taken, following the criteria set by the International Society for the Advancement of Kinanthropometry (ISAK) [84]. A worker's weight in kilograms was divided by their height in square meters to determine their body mass index (BMI) [85]. Hypertension was defined as systolic pressure ≥140 mmHg, diastolic pressure ≥90 mmHg, or continuous antihypertensive therapy in the 2023 ESH European Hypertension guideline update [86,87].
Blood glucose, HDL cholesterol, total cholesterol, and triglycerides were measured. Cut-off levels of metabolic parameters were determined by consulting the International Diabetes Federation (IDF) [88], the National Cholesterol Education Program Expert Panel on the Detection, Evaluation, and Treatment of High Cholesterol in Adults (NCEP/ATPIII) [89], the American Association of Clinical Endocrinologists (AACE) [90], and the Joint Societies Guidelines on Management of Cholesterol [91]. Total cholesterol above 200 mg/dl (5.2 mmol/l), HDL cholesterol below 40 mg/dL (1.03 mmol/L) in men and below 50 mg/dL in women, or treatment for hyperlipidemia were all considered forms of hypercholesterolemia. A blood triglyceride level of more than 150 mg/dL (1.7 mmol/L) was considered hypertriglyceridemia. A plasma glucose level higher than 100 mg/dL (5.6 mmol/L) or the use of hypoglycemic medicine was considered high fasting glucose. The National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria [89] defined metabolic syndrome (MetS) as the presence of three or more of the five risk factors listed above: elevated triglycerides, reduced HDL cholesterol, elevated blood pressure, elevated fasting glucose, and abdominal obesity.

2.3. Statistics

We used the Anderson-Darling test [92] to determine if the variables of interest had a normal distribution. For variables that did not follow a normal distribution, nonparametric approaches were adopted; nevertheless, as Lumley [93] recommended, the sample size persuaded us that parametric methods could be applied even in cases where this assumption was not satisfied.
The Clopper–-Pearson exact test was used to establish 95% confidence intervals (95% CI) of the prevalences. Comparisons between proportions were performed using the chi-square test. Continuous variables were compared using Mann-Whitney U and Student t-test, with effect size assessed using Cohen's D. The correlation between the variables was assessed using both Pearson’s r and Spearman’s rho.
To investigate the strength of these associations, systems of logistic regression equations were constructed, in which the dependent variable was: i) the presence of metabolic syndrome; ii) the experience of psychological distress; iii) having sustained an injury, whether at work, at home, or on the road, during the previous year. For each of the three systems, models of increasing complexity were constructed; the first of these included only the HRO condition, age, and gender. More complex models introduced, at various hierarchical levels, factors related to work, factors related to sleep, and finally, in the most complex model (Model IV), other factors potentially associated with the dependent variable.
The SPSS software package, version 31.0 (IBM Corp., Armonk, New York, USA, 2026), was used for statistical analyses.

3. Results

A total of 2,226 people from 54 small companies in the Latium region participated in the project. The majority were women (1,506, 67.7%). Mean age was 47.6±9.4 years. The values of the continuous variables and the test for normality of the distribution are presented in Table 1. All Anderson-Darling test values were highly significant (p<0.001), indicating that variables did not follow normal distribution. However, the sample size also allowed for the use of parametric tests, as shown by the fact that the median values of the variables are close to the mean values.
In the sample, according to the Berlin questionnaire, 348 workers, i.e. 15.6% (CI95% 14.1; 17.2) were at high risk of OSA (HRO). High-risk status for OSA was more common in males (146, 20.3%) than in females (202, 13.4%) (chi square p<0.001). Workers at high risk of OSA (HRO) had a significantly higher average age than the others (50.8±8.1 vs. 47.0±9.5, Student’s t p<0.001). The effect size was medium (Cohen’s D= -0.408; CI95% -0.523; -0.293).
Excessive daytime sleepiness (EDS) was reported by 394 workers, 17.7% (CI 95% 16.1; 19.4). Among workers with symptoms of OSA, just over a quarter (92, 26.4%) reported daytime sleepiness. Most EDS cases (76.6%) were not associated with symptoms of sleep apnea.
Poor sleep quality was reported by 990 workers, 44.5% (CI95% 42.4; 46.6) of the sample. Among the HROs, the majority (238, 68.4%) had poor sleep quality. Conversely, among poor sleepers, 752 (76.0%) did not have symptoms of OSA. A partial association was also found between sleepiness and sleep quality: just over half of the workers who reported excessive daytime sleepiness (EDS) had poor sleep quality (233, 59.1%), whereas most poor sleepers (757, 76.5%) failed to report sleepiness.
Excessive stress, characterized by a discrepancy between work effort and the rewards gained, was reported by 1,291 out of 2,214 workers (58.3%, CI95% 56.2; 60.4). Across the entire sample, 956 workers (42.9%, CI95% 40.9; 45.0) had a GHQ-12 score indicative of the presence of common mental disorders.
Overall, 167 workers (7.5%, CI95% 6.4; 8.7) reported having suffered an occupational injury in the previous year, and 264 (11.9%, CI95% 10.5; 13.3) reported having suffered a domestic accident. A total of 187 employees (8.0; CI95% 6.9; 9.2) reported having been involved in a road accident while driving. Considering all incidents, 502 workers (22.6%, 95%CI 20.8; 24.3) reported having sustained at least one workplace injury, domestic injury, or road traffic accident in the previous year.
Numerous workers were found to have hypertension, dyslipidemia, obesity, or hyperglycemia during workplace screenings, or were already undergoing treatment for these conditions. Overall, 295 workers suffered from MetS (13.3%, CI95% 11.9; 14.7).
To evaluate the association between OSA symptoms and occupational or health-related variables, we firstly compared the mean scores of the HRO workers and their colleagues. HROs reported significantly higher levels of work annoyance, work-related stress and overcommitment, and lower levels of social support, job satisfaction and work ability than other workers. They also reported lower sleep quality, higher daytime sleepiness, and lower mental health and happiness than their colleagues (Table 2).
We then observed the association of HRO status and metabolic disorders. All metabolic disorders were two to four times more frequent in HROs than in other workers (Table 3).
Subsequently, we evaluated the association between HRO status and the adverse events workers reported experiencing in the 12 months prior to their medical examination. HRO workers reported a significantly higher frequency of workplace and domestic injuries than their colleagues. Driving accidents were more frequent among HROs, though the difference compared to other workers was not significant. However, HROs reported experiencing micro-sleeps or near-miss incidents while driving more frequently than their colleagues (Table 4).
We then examined the correlations between these variables. The presence of OSA symptoms was significantly and positively correlated with male gender and age, as well as with work annoyance, stress, and overcommitment. Social support, job satisfaction, and work ability were inversely correlated with HRO. OSA risk was positively correlated with poor sleep quality, sleepiness, and poor mental health, and negatively correlated with life happiness (Table 5).
To assess the significance of these associations of HRO with workers' health, we constructed three hierarchical logistic regression systems: the first with mental distress (GHQ12 score of 11 or more) as the dependent variable; the second with MetS (defined as the presence of at least three of the following conditions: hypertension, low HDL cholesterol, hypertriglyceridemia, hyperglycemia, and abdominal obesity) as .the dependent variable; the third with driving, home and work accidents as the dependent variable.
In the system of equations with reference to mental health, model I inluded HRO status, sex, and age as independent variables. The three variables were very significantly associated with mental health, but the model had a very low coefficient of determination (R² = 0.07). In Model II, including work-related variables, HRO remained a highly significant predictor, as did all occupational variables. The coefficient of determination increased (R² = 0.394). HRO status significantly increased the risk of mental distress, as did job annoyance, occupational stress, and overcommitment; female gender was associated with a marginally significant increase in risk, whereas social support, job satisfaction, and work ability were associated with a significant protective effect on mental disorders. In Model III, when sleep quality and sleepiness were added, the coefficient of determination reached 48%. In this model, gender lost significance, while the other independent variables remained significant. Finally, model IV, which included life happiness, had a coefficient of determination for mental health above 50%. In this final model, the risk of mental disorders was significantly determined by HRO, poor sleep quality, sleepiness, job annoyance, stress, and overcommitment, whereas social support and happiness had a statistically highly significant protective effect (Table 6).
In the logistic regression model with metabolic syndrome as the dependent variable, Model I showed that HRO status was associated with an almost fivefold increase in risk. The increase in risk associated with age was also highly significant, whereas female gender appeared to be protective. These three variables remained highly significant in Model II (adjusted for work-related variables), Model III (which introduced sleep-related variables), and Model IV (which added lifestyle factors). The coefficient of determination for all these models was modest. In the final model, workers with symptoms of apnea showed an OR of 4.7 (95% CI: 3.4–6.4) for MetS, women had half the risk of males, and each year of life increased the risk by nearly 5% (Table 7).
Accident prediction models indicated that HRO was significantly associated with domestic, workplace, and driving accidents in Model I. This association persisted in Model II, which was adjusted for stress. However, in model III, sleep quality and sleepiness became the dominant factors, together with stress, while HRO lost significance. Model IV, which incorporated emotional variables and lifestyle factors, showed no significant changes: accidents remained primarily correlated with poor sleep quality, sleepiness, and stress. All models, even the most complex ones, had an extremely low predictive value (Table 8).

4. Discussion

In this study, we observed that one in six workers undergoing health surveillance in numerous small and micro-enterprises in the Latium region, exhibited symptoms consistent with OSA. HRO workers had a higher prevalence of metabolic diseases than their colleagues and an almost fivefold risk of suffering from metabolic syndrome. Workers with symptoms of OSA had a significantly higher risk of suffering from mental health problems such as anxiety, depression, or other mental disorders. HROs also reported having experienced a higher rate of workplace and domestic injuries over the previous year compared to colleagues without symptoms. These findings reinforce the view that it is appropriate to investigate the risk of OSA in the workplace, even in those work sectors that are not traditionally recognized as having a high risk of accidents, such as professional driving, night work or construction, or in small and micro-enterprises that generally lack the resources to support health promotion campaigns.
On average, Italian companies have four employees; 95% of Italian businesses have fewer than ten employees. For this reason, health promotion programs in Italy must be extremely low-cost. A lack of financial resources and planning capacity limits the feasibility of implementing health promotion programs in small and micro-enterprises [94,95,96], even though health promotion can be effective in these small businesses [97]. To overcome these obstacles, our university has for many years taken on the task of designing and developing these projects and conducting a statistical analysis of the data, thereby making the projects available free of charge to occupational physicians even in small and micro-companies.
Workplace medical examinations have to be conducted within timeframes scheduled to align with operational requirements. The BQ is suitable for workplace use because it is easy to complete and quick to evaluate, thereby limiting the time needed during the medical procedures themselves. It has proven effective in screening populations [98], demonstrating the best diagnostic performance and the highest positive predictive value [99], even though it shows moderate performance in hospital case series, with high sensitivity but low specificity [100,101,102,103,104]. While it is short enough to be used in the workplace, an Italian study has shown that a shortened version of the BQ, consisting of just three questions, can have a value similar to that of the full version [105] and is therefore recommended for large-scale screening.
The prevalence of HRO observed in this heterogeneous group of small businesses lies at the lower end of the range found in the most frequently studied sectors. In professional drivers, cross-sectional studies reported prevalence data ranging between 11.5% [106], 19.2% [107], 21.5% [108], 24% [109], 26% [110], 29% [111], 35.5% [112], 41% [113], 43.5% [114], and 51.1% [115]. According to a meta-analysis, the pooled OSA prevalence in professional drivers is 41% for apnea hypopnea-index (AHI) greater than 5, and 15% for AHI greater than 15 [116]. A 35.5% rate has been found in railway workers [117], and 69-71% in airline pilots [118,119]. Healthcare workers reported prevalence rates ranging from 7 to 37% in various studies, with a pooled estimate of 23% [120]. Medical students had a 14.5% rate [121], and college students 19% [122]. Military personnel reported an 8% HRO rate in a Taiwanese study [123], and 30.4% in a US study [124].
In our project, workers who tested positive during screening (HROs) were advised to undergo further examinations with their primary care physician and at National Health Service facilities. Diagnosis can be obtained via traditional polysomnography or newer methods that have been shown to be a cost-effective alternative to oximetry [125]. It is probable that not all workers with OSA symptoms will need to seek medical treatment. In most cases, the application of certain principles regarding sleep apnea and the use of positional therapy can be effective [126]. Other workers will benefit from medical treatment for OSA and associated disorders. Longitudinal monitoring in the workplace would be highly valuable for tracking the progression of disorders and response to therapy; the occupational physician can promptly alert the specialist in case of CPAP resistance, a condition affecting a significant proportion of treated workers [127].
Our observations have confirmed that OSA is often associated with metabolic disorders. Similar results have been observed in previous studies conducted in workplaces [128,129] and among migrant workers [130]. Indeed, meta-analytic studies have shown that more than 50% of patients with OSA suffer from metabolic syndrome [9]. We believe that this association is the most important reason for conducting OSA screening in the workplace, since failure to recognize and address OSA may make the treatment of metabolic disorders ineffective. As regards the epidemiologic characteristics of the MetS, our sample confirmed evidence from the literature. Metabolic health depends significantly on age [131,132] and gender [133]: older men are the most affected. Lifestyle factors can complete the picture of metabolic disorders [134,135].
Our observations also confirmed the association between OSA symptoms and mental health. A significant number of workers in this sample reported excessive psychosocial strain and mental health issues. The frequency of these problems is similar to that observed by EU-OSHA among European workers in the most recent OSH-Pulse 2025 survey [136]. The literature has documented a possible bidirectional relationship between OSA and mental health [137]: individuals with various mental illnesses exhibit a higher incidence of OSA [138,139], while patients with OSA suffer from neuropsychological problems [140,141]. According to recent hypotheses, this relationship between OSA and mental disorders could be mediated by changes in oro- and nasopharyngeal microbiota [142]. However, it is important to note that the association observed in this study involved active workers who were all fit for their occupational duties rather than patients with OSA or individuals undergoing treatment for mental illness, that is to say, a population that can reasonably be considered to have a better health status than the general population. It is interesting to note that the relationship between HRO and mental health is already evident before sleep disorders and psychiatric conditions reach clinical significance. Although the exact mechanism underlying this relationship is not known, this should prompt timely intervention in cases of sleep apnea.
Another aspect we want to underline is that, in the system of equations concerning mental health, all work-related factors were playing a significant role. Not only perceived work-related stress but also "work annoyance", i.e. intolerance toward the potential occurrence of specific working conditions, were significantly linked with poor mental health. Overcommitment was also associated with poor mental health, whereas social support, job satisfaction, and work ability were contributing to well-being. In Model III, sleep quality and sleepiness played a dominant role that was independent of the other variables. Although our observations were cross-sectional and cannot provide indications regarding ultimate outcomes, we can reasonably presume that poor sleep quality and daytime sleepiness can be viewed both as an early sign of mental health deterioration and as a mediator of the relationship between environmental factors and mental health. Longitudinal studies could be useful for testing these hypotheses. Pending such developments, those responsible for risk prevention in the workplace should pay close attention to psychosocial indicators. Intolerance toward certain working conditions, excessive perceived stress, and over-dedication to work could be early signs of deterioration in mental health, a decline that must be prevented.
The system of hierarchical logistic regressions used to examine the relationship between HRO and injuries, while confirming that sleep apnea, like stress and excessive work commitment, is significantly associated with accidents, has shown that the impact of these factors is overshadowed by the role of poor sleep quality and daytime sleepiness. Quite apart from the fact that accidental events are difficult to predict, and indeed, the complex systems of equations we constructed accounted for only a modest portion of the total variance, we wish to emphasize that our observations indicated the widespread poor quality of sleep. The workers we monitored reported a largely prevalent poor sleep quality. Only a subset of these poor sleepers were suspected cases of OSA. Poor sleep quality is a major public health issue, the causes of which certainly include cultural and social factors [143]. Among occupational risks, perceived stress [144], post-traumatic stress [145] and long-term night shifts [146,147] are commonly identified as possible causal factors of sleep quality [148]. However, HRO, sleep quality, and sleepiness were not always associated. Only a quarter of suspected OSA patients reported EDS, while the expected prevalence of EDS in OSA cases, based on the literature, should be 39.9% (95% CI: 34.4-45.7) [149]. A significant percentage of the workers who reported excessive daytime sleepiness (140, 35.5%) had neither apnea nor poor sleep quality. There are two possible explanations for this: the first is that, within our sample, only a few HROs actually had a medical condition severe enough to cause sleepiness; the second is that the Epworth Sleepiness Scale ESS, although it is the most widely used method for self-assessing daytime sleepiness, is not the most useful tool for monitoring the risk of accidents due to OSA. The main problem with the Epworth scale is that it does not distinguish between sleepiness and fatigue and consequently provides inconsistent information [150]. Moreover, it lacks gender invariance [151]. In fact, studies on commercial drivers showed poor correlations between OSA and fatal crashes and between EDS and OSA severity [152]. In occupational studies, the EDS has not proven to be a reliable tool, not only due to the scale's low internal consistency, but also because of intentional under-reporting by workers who fear suspension of their driver's license [153]. On account of the current lack of validated tools providing more reliable measurements of sleepiness, the ESS should be used with considerable caution, and the information it yields should be supplemented with data from other sources.
A key strength of our study is that it involved a large number of workers from many small companies and measured the risk of OSA and associated conditions by using a very simple and cost-effective method. To the best of our knowledge, there are no other studies that have considered such a wide range of occupational, metabolic, psychological, and lifestyle-related issues. The observations we conducted has led us to believe that OSA screening should be part of health surveillance. Occupational health services could follow up on these investigations by assessing the direction of the associations using longitudinal study designs. The use of bracelet- or ring-based remote monitoring devices could enable a shift from symptom detection to monitoring the status of the condition. Collaboration with primary healthcare services and sleep medicine centers could provide data collected from continuous workplace monitoring, thereby increasing the effectiveness of specialized therapies and improving workers' quality of life.
Alongside these strengths and achievable prospects, the experience described here has many weaknesses. The first is the cross-sectional nature of our observations, which, while common to most workplace studies, fails to determine the direction of the observed associations. Reverse causation can never be ruled out, although clinical studies in the literature help to correctly interpret the observations. The subjective nature of most of the information collected limits the reliability of the results since under-reporting or over-reporting must always be considered, even though the medical examination performed immediately after the questionnaires are completed helps correct statements that do not reflect reality. The use of short, standardized questionnaires, typical of occupational epidemiology, provides less detailed information than that obtainable with more complex instruments. The voluntary nature of participation in health promotion activities introduces a selection bias that cannot be eliminated, even in cases such as this one where participation was extremely high. Finally, the extremely heterogeneous nature of the workforce precluded the analysis of numerous occupational, economic, educational, social, and familial factors that could influence sleep and sleep apnea. Nevertheless, this heterogeneity may render the sample reasonably representative of the population of small and micro-enterprises.
In essence, this study serves as a starting point for more extensive and long-term investigations. The techniques employed in this survey are available free of charge to physicians or companies wishing to expand upon these observations. We support the recent call by Kinoshita et al. [ref] to screen for OSA in high-risk occupations, and we believe that such screening should be extended to all occupations.

5. Conclusions

A survey conducted in numerous small businesses has shown that the risk of sleep apnea is widespread and strongly associated with the risk of metabolic syndrome. HRO is also significantly associated with the risk of poor mental health and has a weak association with the risk of occupational, domestic or driving injuries. For all these reasons, it is advisable to screen OSA in the workplace.

Author Contributions

Conceptualization, N.M.; methodology, N.M.; formal analysis, N.M.; data curation, N.M.; writing—original draft preparation, N.M.; writing—review and editing, N.M, and L.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Università Cattolica del Sacro Cuore, Policlinico Gemelli Foundation, in Rome (prot. N. 1226 24/11/2016).

Data Availability Statement

Data collected during the study have been deposited in a publicly available repository (DOI 10.5281/zenodo.23770854).

Acknowledgments

We thank EA Wright who corrected the language. No GenAI has been used for purposes such as generating text, data, or graphics, or for study design, data collection, analysis, or interpretation of data.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
AACE American Association of Clinical Endocrinologists
AKQ Abdel-Khalek questionnaire
BQ Berlin Questionnaire
CPAP continuous positive airway pressure
ERI Effort Reward Imbalance
ESS Epworth Sleepiness Scale
GHQ-12 General Health Questionnaire, 12-item version
HRO High risk of obstructive sleep apnea
ISAK International Society for the Advancement of Kinanthropometry
NCEP National Cholesterol Education Program
OSA Obstructive Sleep Apnea
OSH Occupational safety and health
PIP Promotion in Prevention
PSQI Pittsburgh Sleep Quality Index
TWH Total Worker Health
WAS Work Annoyance Scale

References

  1. Anttalainen, U.; Tenhunen, M.; Rimpilä, V.; Polo, O.; Rauhala, E.; Himanen, S.L.; Saaresranta, T. Prolonged partial upper airway obstruction during sleep - an underdiagnosed phenotype of sleep-disordered breathing. Eur. Clin. Respir. J. 2016, 3, 31806. [Google Scholar] [CrossRef]
  2. Slowik, J.M.; Sankari, A.; Collen, J.F. Obstructive Sleep Apnea. In StatPearls [Internet]; StatPearls Publishing: Treasure Island (FL), 4 Mar 2025; Available online: https://www.ncbi.nlm.nih.gov/books/NBK459252/ (accessed on 10 August 2026).
  3. Blunden, S.; Lushington, K.; Lorenzen, B.; Ooi, T.; Fung, F.; Kennedy, D. Are sleep problems under-recognised in general practice? Arch. Dis. Child 2004, 89(8), 708–12. [Google Scholar] [CrossRef]
  4. Westreich, R.; Gozlan-Talmor, A.; Geva-Robinson, S.; Schlaeffer-Yosef, T.; Slutsky, T.; Chen-Hendel, E.; Braiman, D.; Sherf, Y.; Arotsker, N.; Abu-Fraiha, Y.; Waldman-Radinsky, L.; Maimon, N. The Presence of Snoring as Well as its Intensity Is Underreported by Women. J. Clin. Sleep Med. 2019, 15(3), 471–476. [Google Scholar] [CrossRef]
  5. Soni, S.J. Improving the screening process for obstructive sleep apnea in the primary care setting. J. Am. Assoc. Nurse Pract. 2023, 35(11), 731–739. [Google Scholar] [CrossRef]
  6. Al-Rasheedi, A.N.; Thirunavukkarasu, A.; Almutairi, A.; Alruwaili, S.; Alotaibi, H.; Alzaid, W.; Albalawi, F.; Alwadani, O.; Dilli, A. Knowledge and Attitude towards Obstructive Sleep Apnea among Primary Care Physicians in Northern Regions of Saudi Arabia: A Multicenter Study. Healthcare 2022, 10(12), 2369. [Google Scholar] [CrossRef]
  7. Show, K.L.; Lim, Z.Y.; Teong, C.C.Y.; Sng, E.H.Y.; Lee, E.K.; Moosa, A.S.; Ng, C.J. Global prevalence of nocturnal hypertension: systematic review and meta-analysis. BMC Public Health 2026, 26(1), 2358. [Google Scholar] [CrossRef]
  8. Yang, Y.; Pan, Y.; Cao, F.; Chen, H.; Wang, L. Stroke patients with obstructive sleep Apnea: Risk of cardiovascular diseases - A systematic review and meta-analysis. Sleep Med. 2025, 134, 106667. [Google Scholar] [CrossRef]
  9. Pant, S.; Kyrou, I.; Dallaway, A.; Kite, C.; Lagojda, L.; Asad, A.; Dhungana, A.; Randeva, H.S.; Kurmi, O.P. Global prevalence of metabolic syndrome in adults with obstructive sleep apnoea: A systematic review and meta-analysis. Sleep 2026, 49(9), zsag144. [Google Scholar] [CrossRef]
  10. Peker, Y.; Hedner, J.; Norum, J.; Kraiczi, H.; Carlson, J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am. J. Respir. Crit. Care Med. 2002, 166(2), 159–65. [Google Scholar] [CrossRef]
  11. Nguyen, D.; Hoang, C.; Truong, T.; Nguyen, D.; Lam, H.G.; Sharma, A.; Le, T.Q.; Huynh, P.K. Multi-level phenotypic models of cardiovascular disease and obstructive sleep apnea comorbidities: A longitudinal Wisconsin sleep cohort study. PLoS ONE 2025, 20(7), e0327977. [Google Scholar] [CrossRef]
  12. Cai, X.; Hu, J.; Wen, W.; Wang, J.; Wang, M.; Liu, S.; Zhu, Q.; Hong, J.; Dang, Y.; Yao, X.; Sun, L.; Zhang, D.; Luo, Q.; Li, N. Associations of the Cardiometabolic Index with the Risk of Cardiovascular Disease in Patients with Hypertension and Obstructive Sleep Apnea: Results of a Longitudinal Cohort Study. Oxid. Med. Cell Longev. 2022, 2022, 4914791. [Google Scholar] [CrossRef]
  13. Srimoragot, M.; Reutrakul, S.; Hershberger, P.E.; Park, C.; Quinn, L.; Liese, K.L.; Balserak, B.I. The association between obstructive sleep apnea risk and cardiovascular disease risk in midlife Thai women in the U.S. J. Clin. Sleep Med. 2026, 22(1), 26. [Google Scholar] [CrossRef]
  14. Su, K.; Feng, Z.; Wang, L.; Zhao, G.; Li, J. Prevalence of cognitive impairment among adults with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath 2025, 29(6), 323. [Google Scholar] [CrossRef]
  15. Ren, Y.; Chen, S.; Wang, H.; Zou, C.; Xie, Q.; Wu, Y.; Sun, D.; Yang, Y.; Zhou, L. Unraveling the bidirectional links between obstructive sleep apnea and mild cognitive impairment: A systematic review and meta-analysis. Sleep Med. 2025, 132, 106562. [Google Scholar] [CrossRef]
  16. Garbarino, S.; Bardwell, W.A.; Guglielmi, O.; Chiorri, C.; Bonanni, E.; Magnavita, N. Association of Anxiety and Depression in Obstructive Sleep Apnea Patients: A Systematic Review and Meta-Analysis. Behav. Sleep Med. 2020, 18(1), 35–57. [Google Scholar] [CrossRef]
  17. Edwards, C.; Almeida, O.P.; Ford, A.H. Obstructive sleep apnea and depression: A systematic review and meta-analysis. Maturitas 2020, 142, 45–54. [Google Scholar] [CrossRef]
  18. Papageorgiou, S.N.; Konstantinidis, I.; Papadopoulou, A.K.; Apostolidou-Kiouti, F.; Avgerinos, I.; Pataka, A.; Eliades, T.; Tsapas, A.; Haidich, A.B. Comparative efficacy of non-pharmacological interventions for adults with sleep apnea: A systematic review and network meta-analysis. Sleep Med. 2025, 128, 130–138. [Google Scholar] [CrossRef]
  19. Pauletto, P.; Réus, J.C.; Bolan, M.; Massignan, C.; Flores-Mir, C.; Maia, I.; Gozal, D.; Hallal, A.L.C.; Porporatti, A.L.; Canto, G.L. Association between obstructive sleep apnea and health-related quality of life in untreated adults: a systematic review. Sleep Breath 2021, 25(4), 1773–1789. [Google Scholar] [CrossRef]
  20. Shi, X.; Ke, J.; Wu, X.; Wang, Y.; Wang, Y. Obstructive sleep apnea symptom phenotypes and physical health approximately 5 years later in the Sleep Heart Health Study. Sleep Med. 2026, 149, 109297. [Google Scholar] [CrossRef]
  21. Garbarino, S. Apnee ostruttive nel sonno (OSA) e Sicurezza alla Guida [Obstructive sleep apnea (OSA) and driving safety]. Med. Lav.;Italian 2017, 108(4), 297–303. [Google Scholar] [CrossRef]
  22. Mukherjee, S.; McDonald, A.D.; Kesler, S.R.; Cuevas, H.; Swank, C.; Stevens, A.; Ferris, T.K.; Danesh, V. Driving among individuals with chronic conditions: A systematic review of applied research using kinematic driving sensors. J. Am. Geriatr. Soc. 2024, 72(4), 1242–1251. [Google Scholar] [CrossRef]
  23. Zafar, A.; Roman, U.; Haseeb, A.; Akhtar, T. Reliability of Home Sleep Apnea Test as a Diagnostic Modality in Children With Obstructive Sleep Apnea- a Systematic Review. Pediatr. Pulmonol. 2026, 61(5), e71674. [Google Scholar] [CrossRef]
  24. Chen, G.; Zhang, M.; Zhou, J.; Wang, T.; Zhu, M.; Liu, Z. The diagnostic value of polysomnography in obstructive sleep apnea-hypopnea syndrome patients with hypertension and secondary atherosclerosis. Am. J. Transl. Res. 2025, 17(5), 3928–3938. [Google Scholar] [CrossRef]
  25. van Doorn, S.; Idema, D.L.; Heus, P.; Damen, J.A.; Spijker, R.; Japenga, E.J.; Reesink, H.J.; Hooft, L. Clinical utility of limited channel sleep studies versus polysomnography for obstructive sleep apnoea. Cochrane Database Syst. Rev. 2025, 5(5), CD013810. [Google Scholar] [CrossRef]
  26. Kim, D.H.; Jang, D.W.; Hwang, S.H. Comparison of upper airway stimulation, tongue base surgeries, and continuous positive airway pressure for moderate-to-severe obstructive sleep apnea: a systematic review and network meta-analysis. Sleep Breath 2026, 30(4), 226. [Google Scholar] [CrossRef]
  27. Sajith Kumar, S.; Suchitra Lakshmi, G.; Sohail, A.; Jagadeesh, K.V.; Bagepally, B.S. Cost effectiveness of obstructive sleep apnea therapies: a systematic review and meta-analysis of cost utility studies. Expert Rev. Pharmacoecon Outcomes Res. 2025, 25(4), 507–515. [Google Scholar] [CrossRef]
  28. Malhotra, A.; Ayappa, I.; Ayas, N.; Collop, N.; Kirsch, D.; Mcardle, N.; Mehra, R.; Pack, A.I.; Punjabi, N.; White, D.P.; Gottlieb, D.J. Metrics of sleep apnea severity: beyond the apnea-hypopnea index. Sleep 2021, 44(7). [Google Scholar] [CrossRef]
  29. Benjafield, A.V.; Ayas, N.T.; Eastwood, P.R.; Heinzer, R.; Ip, M.S.M.; Morrell, M.J.; Nunez, C.M.; Patel, S.R.; Penzel, T.; Pépin, J.L.; Peppard, P.E.; Sinha, S.; Tufik, S.; Valentine, K.; Malhotra, A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir. Med. 2019, 7(8), 687–698. [Google Scholar] [CrossRef] [PubMed]
  30. de Araujo Dantas, A.B.; Gonçalves, F.M.; Martins, A.A.; Alves, G.Â.; Stechman-Neto, J.; Corrêa, C.C.; Santos, R.S.; Nascimento, W.V.; de Araujo, C.M.; Taveira, K.V.M. Worldwide prevalence and associated risk factors of obstructive sleep apnea: a meta-analysis and meta-regression. Sleep Breath 2023, 27(6), 2083–2109. [Google Scholar] [CrossRef]
  31. Bassetti, C.L.A.; Welter, L.S.; Montes-Martinez, M.; Mühlberger, N.; Boon, P.; Berger, T.; Deuschl, G.; Arvandi, M.; Konti, M.; Lolich, M.; Pajediene, E.; Fronczek, R.; Moro, E.; Siebert, U.; Dodel, R. Epidemiology and Economic Burden of Sleep Disorders in Europe. Eur. J. Neurol. 2026, 33(2), e70463. [Google Scholar] [CrossRef]
  32. Peppard, P.E.; Young, T.; Barnet, J.H.; Palta, M.; Hagen, E.W.; Hla, K.M. Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol. 2013, 177(9), 1006–14. [Google Scholar] [CrossRef]
  33. Patel, S.R.; Ryan, S. Should weight loss be the first-line treatment for obstructive sleep apnoea? A pro-con debate. Eur. Respir. Rev. 2026, 35(180), 250255. [Google Scholar] [CrossRef]
  34. Black, J.K.; Whittaker, A.C.; Balanos, G.M. Undiagnosed Obstructive Sleep Apnea and Physical Activity in Older Manual Workers. J. Aging Phys. Act. 2019, 27(3), 293–299. [Google Scholar] [CrossRef]
  35. APS Associazione Italiana Apnee del Sonno. Available online: https://www.apneedelsonno.it/chi-siamo/ (accessed on 16 August 2026).
  36. Intelligence, Mordor. Analisi delle dimensioni e della quota di mercato dei dispositivi respiratori in Italia - Tendenze di crescita e previsioni (2026-2031) [Respiratory Devices Market Size and Share Analysis in Italy - Growth Trends and Forecasts (2026-2031)]. Available online: https://www.mordorintelligence.it/industry-reports/italy-respiratory-devices-market (accessed on 16 August 2026).
  37. Kapur, V.; Strohl, K.P.; Redline, S.; et al. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath 2002, 6, 49–54. [Google Scholar] [CrossRef]
  38. Savin, K.L.; Loredo, J.S.; Clare, K.; Yoshida, R.; Holloway, B.M.; Owens, R.L.; Nokes, B.; Colvonen, P.J. Obstructive sleep apnea underdiagnosis: Prevalence and correlates from the Sleep Health and Knowledge in US Hispanics study. Sleep Adv. 2026, 7(3), zpag071. [Google Scholar] [CrossRef]
  39. Sajith Kumar, S.; Suchitra Lakshmi, G.; Sohail, A.; Jagadeesh, K.V.; Bagepally, B.S. Cost effectiveness of obstructive sleep apnea therapies: a systematic review and meta-analysis of cost utility studies. Expert Rev. Pharmacoecon Outcomes Res. 2025, 25(4), 507–515. [Google Scholar] [CrossRef]
  40. Zappalà, P.; Lentini, M.; Ronsivalle, S.; Lavalle, S.; La Via, L.; Maniaci, A. The Global Socioeconomic Burden of Obstructive Sleep Apnea: A Comprehensive Review. Healthcare 2025, 13(17), 2115. [Google Scholar] [CrossRef]
  41. Mattila, T.; Kreivi, H.R.; Mäkitalo, L.; Kotanen, P.; Avellan-Hietanen, H.; Kauppi, P. Cost-effectiveness of CPAP treatment in a tax-funded healthcare system - a scoping review and suggestions for cost reduction of CPAP treatment. Eur. Clin. Respir. J. 2025, 12(1), 2518663. [Google Scholar] [CrossRef]
  42. Meng, F.; Ang, G.Y.; Chang, R.R.Y.; Lee, C.P.; Tan, K.B.; Abisheganaden, J.A. Cost-effectiveness analysis of continuous positive airway pressure treatment for obstructive sleep apnea in Singapore from a health system perspective. J. Sleep Res. 2025, 34(2), e14326. [Google Scholar] [CrossRef]
  43. Kinoshita, R.; Sathyapala, A.; Polkey, M.I. Has the time come for workplace screening for obstructive sleep apnoea (OSA)? Thorax 2026, 81, 638–641. [Google Scholar] [CrossRef]
  44. Ko, H.; Cho, S.S.; Lee, D.W.; Choi, J.; Kim, M.S.; Kang, M.Y. The Impact of Comorbid Insomnia and Sleep Apnea (COMISA) on Work Ability: Results From Population-Based Panel Data in Korea. J. Sleep Res. 2026, 35(1), e70096. [Google Scholar] [CrossRef]
  45. Rehman, U.; Ahn, Y.; Yerushalmi, E.; Abdelwahab, M.; Eynon-Lewis, N.; Liu, J.; Sutton, L.; Holsinger, F.C.; Capasso, R.; Côté, M.L.; Cheong, R.C.T.; Kotecha, B.; Ohayon, M.M.; Hafner, M.; Lechner, M. Neglected burden of obstructive sleep apnoea: workplace productivity loss in the USA and UK. Thorax 2026, 81(5), 492–494. [Google Scholar] [CrossRef]
  46. Reynolds, A.C.; Coenen, P.; Lechat, B.; Straker, L.; Zabatiero, J.; Maddison, K.J.; Adams, R.J.; Eastwood, P. Insomnia and workplace productivity loss among young working adults: a prospective observational study of clinical sleep disorders in a community cohort. Med. J. Aust. 2023, 219(3), 107–112. [Google Scholar] [CrossRef]
  47. Garbarino, S.; Guglielmi, O.; Sanna, A.; Mancardi, G.L.; Magnavita, N. Risk of Occupational Accidents in Workers with Obstructive Sleep Apnea: Systematic Review and Meta-analysis. Sleep 2016, 39(6), 1211–8. [Google Scholar] [CrossRef]
  48. Chou, K.T.; Tsai, Y.L.; Yeh, W.Y.; Chen, Y.M.; Huang, N.; Cheng, H.M. Risk of work-related injury in workers with obstructive sleep apnea: A systematic review and meta-analysis. J. Sleep Res. 2022, 31(1), e13446. [Google Scholar] [CrossRef]
  49. Hirsch Allen, A.J.; Peres, B.; Ayas, N.T. Obstructive Sleep Apnea Severity and the Risk of Occupational Injury: A Prospective Observational Cohort. Lung 2020, 198(2), 283–287. [Google Scholar] [CrossRef]
  50. Sansom, K.; Mittinty, M.N.; Dunbar, C.; Vakulin, A.; Adams, R.J.T.; McArdle, N.; Eastwood, P.R.; Reynolds, A. Additive interactions of sleep disorders, insufficient sleep, and shift work on road and workplace safety incidents: A sufficient cause approach with overlap weights. Sleep Med. Erratum in: Sleep Med. 2025;135:106744. doi: 10.1016/j.sleep.2025.106744. 2025, 134, 106699. [Google Scholar] [CrossRef]
  51. National Institute for Occupational Safety and Health. Total Worker Health. Available online: https://www.cdc.gov/niosh/twh/index.html (accessed on 30 July 2026).
  52. Magnavita, N.; Meraglia, I.; Viti, G. Promotion included in prevention (PIP). Eur. J. Public Health 2024, 34, ckae144.1726. [Google Scholar] [CrossRef]
  53. Magnavita, N. Workplace Health Promotion Embedded in Medical Surveillance: The Italian Way to Total Worker Health Program. Int. J. Environ. Res. Public Health 2023, 20, 3659. [Google Scholar] [CrossRef]
  54. Li, Y.; Yin, D.; Deng, S.; Zhai, L.; Wang, L.; Zhang, L.; Zhao, B.; Niu, H.; Gao, X. Mechanistic insights into di(2-ethylhexyl) phthalate exposure in obstructive sleep apnea: network toxicology and in vitro validation. Bioorg Chem. 2026, 182, 110498. [Google Scholar] [CrossRef]
  55. Yang, B.; Yan, M.; Gu, Z.; Niu, Z.; Sun, J.; Guo, J.; Wang, Q.; Yang, Y.; Wang, W. Polycyclic aromatic hydrocarbons are associated with sleep-related disorders in adults: the potential mediating role of inflammation. BMC Public Health 2025, 25(1), 1941. [Google Scholar] [CrossRef]
  56. Ma, S.; Xie, S. Association of ethylene oxide exposure and obstructive sleep apnea. Environ. Health Prev. Med. 2025, 30, 9. [Google Scholar] [CrossRef]
  57. Liu, J.; Liu, Z.; Liu, X.; Wang, N.; Wu, L.; Xu, X.; Liu, W.; Feng, Y.; Zhang, H.; Zhou, Y.; Yin, X.; Liu, Y.; Wu, Q.; Ning, N.; Liang, L. Combined exposure to mixed brominated flame retardants on obstructive sleep apnea syndrome in US adults. BMC Public Health 2025, 25(1), 146. [Google Scholar] [CrossRef]
  58. Lin, C.C.; Lin, P.J.; Hsu, Y.T.; Chang, C.R.; Shih, C.W.; Kuo, C.C.; Shiau, S.C.; Lo, Y.H.; Elisala, N.; Elisala, J.; Tehulu, F.; López-Gil, J.F.; Lee, W.Y.; Hershey, M.S.; Chang, S.H.; Lu, J.Y.; Pan, C.T.; Wei, C.F. Associations of smoking and second-hand smoke exposure with obesity and obstructive sleep apnoea risk in Tuvalu. J. Glob. Health 2026, 16, 04250. [Google Scholar] [CrossRef]
  59. Yang, C.C.; Lee, K.W.; Watanabe, K.; Kawakami, N. The association between shift work and possible obstructive sleep apnea: a systematic review and meta-analysis. Int. Arch. Occup. Environ. Health 2021, 94(8), 1763–1772. [Google Scholar] [CrossRef]
  60. Netzer, N.C.; Stoohs, R.A.; Netzer, C.M.; Clark, K.; Strohl, K.P. Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann. Intern Med. 1999, 131, 485–491. [Google Scholar] [CrossRef]
  61. Curcio, G.; Tempesta, D.; Scarlata, S.; Marzano, C.; Moroni, F.; Rossini, P.M.; Ferrara, M.; De Gennaro, L. Validity of the Italian version of the Pittsburgh Sleep Quality Index (PSQI). Neurol. Sci. 2013, 34(4), 511–9. [Google Scholar] [CrossRef]
  62. Buysse, D.J.; Reynolds, C.F.; Monk, T.H.; Berman, S.R.; Kupfer, D.J. The Pittsburgh Sleep Quality Index (PSQI): A new instrument for psychiatric research and practice. Psychiatry Res. 1989, 28(2), 193–213. [Google Scholar] [CrossRef] [PubMed]
  63. Vignatelli, L.; Plazzi, G.; Barbato, A.; Ferini-Strambi, L.; Manni, R.; Pompei, F.; D'Alessandro, R. Italian version of the Epworth sleepiness scale: external validity. Neurol. Sci. 2003, 23(6), 295–300. [Google Scholar] [CrossRef]
  64. Johns, M.W. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 1991, 14(6), 540–5. [Google Scholar] [CrossRef] [PubMed]
  65. Trimmel, K.; Żebrowska, M.; Böck, M.; Stefanic, A.; Mayer, D.; Klösch, G.; Auff, E.; Seidel, S. Wanted: a better cut-off value for the Epworth Sleepiness Scale. Wien. Klin. Wochenschr. 2018, 130(9-10), 349–355. [Google Scholar] [CrossRef]
  66. Pouliot, Z.; Peters, M.; Neufeld, H.; Kryger, M.H. Using self-reported questionnaire data to prioritize OSA patients for polysomnography. Sleep 1997, 20(3), 232–6. [Google Scholar] [CrossRef]
  67. Magnavita, N.; Chiorri, C. Development and Validation of a New Measure of Work Annoyance Using a Psychometric Network Approach. Int. J. Environ. Res. Public Health 2022, 19(15), 9376. [Google Scholar] [CrossRef]
  68. Magnavita, N.; Garbarino, S.; Siegrist, J. The use of parsimonious questionnaires in occupational health surveillance. Psychometric properties of the short Italian version of the Effort/Reward Imbalance questionnaire. TSWJ Sci. World J. 2012, 2012, 372852. [Google Scholar] [CrossRef]
  69. Siegrist, J. Adverse health effects of high-effort/low-reward conditions. J. Occup. Health Psychol. 1996, 1, 27–41. [Google Scholar] [CrossRef]
  70. Johnson, J.V.; Hall, E.M. Job strain, work place support, and cardiovascular disease. A cross sectional study of a random sample of the Swedish working population. Am. J. Public Health 1988, 78, 1336. [Google Scholar] [CrossRef]
  71. Magnavita, N. Two tools for health surveillance of job stress: The Karasek Job Content Questionnaire and the Siegrist Effort Reward Imbalance Questionnaire. G. Ital. Med. Lav. Ergon. 2007, 29(3), 667–670. [Google Scholar]
  72. Karasek, R.A. Job demands, job decision latitude, and mental strain. Implication for job redesign. Adm. Sci. Q. 1979, 24, 285. [Google Scholar] [CrossRef]
  73. Magnavita, N.; Fileni, A.; Magnavita, L.; Mammi, F.; Roccia, K.; De Matteis, B.; Colozza, V.; Vitale, M.R. Soddisfazione da lavoro. Uso della Job Satisfaction Scale. Job satisfaction. Use of the Job Satisfaction Scale (JSS). G. Ital. Med. Lav. Ergon. 2007, 29(3), 655–657. [Google Scholar]
  74. Warr, P.; Cook, J.; Wall, T. Scales for the measurement of some work attitudes and aspects of psychological well-being. J. Occup. Psychol. 1979, 52, 129–148. [Google Scholar] [CrossRef]
  75. Converso, D.; Sottimano, I.; Garzaro, G.; Guidetti, G.; Pira, E.; Viotti, S. Contribution to validation of the Italian version of work ability personal radar. Med. Lav. 2022, 113(6), e2022051. [Google Scholar] [CrossRef]
  76. Tuomi, K.; Ilmarinen, J.; Jahkola, A.; Katajarinne, L.; Tulkki, A. Work Ability Index, 2nd revised edn; Finnish Institute of Occupational Health: Helsinki, 1998. [Google Scholar]
  77. El Fassi, M.; Bocquet, V.; Majery, N.; Lair, M.L.; Couffignal, S.; Mairiaux, P. Work ability assessment in a worker population: comparison and determinants of Work Ability Index and Work Ability score. BMC Public Health 2013, 13, 305. [Google Scholar] [CrossRef]
  78. Goldberg, D. The detection of psychiatric illness by questionnaire; Oxford University Press, 1972. [Google Scholar]
  79. Banks, M.H.; Clegg, C.W.; Jackson, P.R.; Kemp, N.J.; Stafford, E.M.; Wall, T.D. The use of the General Health Questionnaire as an indicator of mental health in occupational studies. J. Occup. Psychol. 1980, 53, 187–194. [Google Scholar] [CrossRef]
  80. Goldberg, D.; Williams, P.A. User’s guide to the general health questionnaire; NFER-Nelson: Windsor, 1991. [Google Scholar]
  81. Donath, S. The validity of the 12-item general health questionnaire in Australia: a comparison between three scoring methods. Aust. N Z. J. Psychiatr. 2001, 35(2), 231–235. [Google Scholar] [CrossRef]
  82. Goldberg, D.P.; Gater, R.; Sartorius, N.; Ustun, T.B.; Piccinelli, M.; Gureje, O.; et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol. Med. 1997, 27(1), 191–197. [Google Scholar] [CrossRef] [PubMed]
  83. Abdel-Khalek, A.M. Measuring happiness with a single-item scale. In Social Behavior and Personality: An International Journal; Scientific Journal Publishers: Palmerston North, New Zealand, 2006; pp. 139–150. [Google Scholar]
  84. Petri, C.; Campa, F.; Holway, F.; Pengue, L.; Arrones, L.S. ISAK-Based Anthropometric Standards for Elite Male and Female Soccer Players. Sports 2024, 12(3), 69. [Google Scholar] [CrossRef] [PubMed]
  85. UK National Health Service. Calculate your body mass index (BMI) for adults. Available online: https://www.nhs.uk/health-assessment-tools/calculate-your-body-mass-index/calculate-bmi-for-adults (accessed on 20 July 2026).
  86. European Society of Hypertension. 2023 ESH Guidelines for the Management of Arterial Hypertension. Available online: https://www.eshonline.org/guidelines/2023-guidelines/ (accessed on 20 July 2026).
  87. American College of Cardiology. 2023 ESH Hypertension Guideline Update: Bringing Us Closer Together Across the Pond. Available online: https://www.acc.org/latest-in-cardiology/articles/2024/02/05/11/43/2023-esh-hypertension-guideline-update (accessed on 20 July 2026).
  88. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Available online: https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html (accessed on 20 July 2026).
  89. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001, 285, 2486–2497. [CrossRef] [PubMed]
  90. Einhorn, D.; Reaven, G.M.; Cobin, R.H.; Ford, E.; Ganda, O.P.; Handelsman, Y.; Hellman, R.; Jellinger, P.S.; Kendall, D.; Krauss, R.M.; et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr. Pract. 2003, 9, 237–252. [Google Scholar] [CrossRef]
  91. Grundy, S.M.; Stone, N.J.; Bailey, A.L.; Beam, C.; Birtcher, K.K.; Blumenthal, R.S.; Braun, L.T.; de Ferranti, S.; Faiella-Tommasino, J.; Forman, D.E.; Goldberg, R.; Heidenreich, P.A.; Hlatky, M.A.; Jones, D.W.; Lloyd-Jones, D.; Lopez-Pajares, N.; Ndumele, C.E.; Orringer, C.E.; Peralta, C.A.; Saseen, J.J.; Smith, S.C., Jr.; Sperling, L.; Virani, S.S.; Yeboah, J. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation Erratum in: Circulation. 2023;148(7):e5. doi: 10.1161/CIR.0000000000001172. 2019, 139(25), e1082–e1143. [Google Scholar] [CrossRef]
  92. Anderson, T.W.; Darling, D.A. Asymptotic theory of certain “goodness-of-fit” criteria based on stochastic processes. Ann. Math. Stat. 1952, 23, 193–212. [Google Scholar] [CrossRef]
  93. Lumley, T.; Diehr, P.; Emerson, S.; Chen, L. The importance of the normality assumption in large public health data sets. Annu. Rev. Public Health 2002, 23, 151–169. [Google Scholar] [CrossRef] [PubMed]
  94. Hollederer, A. Betriebliche Gesundheitsförderung in Deutschland für alle? Ergebnisse der BIBB-/BAuA-Erwerbstätigenbefragung 2018 [Workplace Health Promotion in Germany for All? Results of the 2018 BIBB/BAuA survey of Employed People]. Gesundheitswesen 2023, 85(4), 277–288. [Google Scholar] [CrossRef]
  95. Schaefer, E.; Drexler, H.; Kiesel, J. Betriebliche Gesundheitsförderung in kleinen, mittleren und großen Unternehmen des Gesundheitssektors - Häufigkeit, Handlungsgründe der Unternehmensleitungen und Hürden der Realisierung [Workplace Health Promotion in Small, Medium-Sized and Large Enterprises of the Health-Care Sector - Frequency, Reasons for the Company Management to Take Action and Barriers to Implementation]. Gesundheitswesen 2016, 78(3), 161–5. [Google Scholar] [CrossRef]
  96. Magnavita, N. Obstacles and Future Prospects: Considerations on Health Promotion Activities for Older Workers in Europe. Int. J. Environ. Res. Public Health 2018, 15(6), pii: E1096. [Google Scholar] [CrossRef]
  97. Willeke, K.; Janson, P.; Kirchner, A.; Tischer, C.; D'Souza, A.; Heuschmann, P.U.; Zapf, A.; Wildner, M.; Stupp, C.; Keil, T. Effects of occupational health promotion interventions on health-related outcomes among employees of small businesses and self-employed individuals: A systematic review. Work 2024, 79(2), 551–567. [Google Scholar] [CrossRef]
  98. Cheung, E.; Shang, Y.; Kong, L.; Khayat, R. Performance of obstructive sleep apnea screening questionnaires in hospitalized patients with heart failure. Sleep Med. 2026, 147, 109087. [Google Scholar] [CrossRef]
  99. Chen, R.; Zhang, Y.; Ye, W.; Chen, Z.; Liao, W.; Liao, H.; Sun, T.; Li, H.; Cheng, J.; Liu, W.; Yao, W.; Yang, Y. Improving OSA screening efficiency with subjective questionnaires: integrating STOP-Bang, ESS, and Berlin. Front Med. 2025, 12, 1581904. [Google Scholar] [CrossRef]
  100. Phuong, T.N.N.; Kim, T.V.; Ho, D.H.; Phuong, T.T.; Le Trang, N.T.; Tuyen, T.T.; Que, B.D.; Hoa, D.T.; Thao, N.T.T.; Duong-Quy, S. Assessment of Clinical Questionnaires for Predicting Obstructive Sleep Apnea in Patients with Non-Valvular Atrial Fibrillation. Pulm. Ther. 2026, 12(2), 561–572. [Google Scholar] [CrossRef]
  101. Asyaei, P.; Johansen, M.S.; Jakobsen, C.; Stokbro, K.; Jensen, S.; Henriksen, J.E.; Højlund, K.; Stidsen, J.V.; Olesen, T.B. Obstructive sleep apnea in type 2 diabetes: prevalence and limitations of the Berlin questionnaire and Epworth sleepiness scale in identifying high-risk patients. Sleep Breath 2025, 29(6), 353. [Google Scholar] [CrossRef]
  102. Shi, C.; Wang, Y.; Luo, J.; Huang, R.; Xiao, Y. Performance of Four Screening Tools for Identifying Obstructive Sleep Apnea Among Patients with Insomnia. Nat. Sci. Sleep 2025, 17, 379–390. [Google Scholar] [CrossRef]
  103. Hukins, C.; Duce, B. Usefulness of self-administered questionnaires in screening for direct referral for polysomnography without sleep physician review. J. Clin. Sleep Med. 2022, 18(5), 1405–1412. [Google Scholar] [CrossRef]
  104. Li, X.; Zha, L.; Zhou, L.; Xu, Y.; Li, X.; Yang, J.; Li, H. Diagnostic utility of obstructive sleep apnea screening questionnaires: a comprehensive meta-analysis. Sleep Breath 2024, 29(1), 14. [Google Scholar] [CrossRef]
  105. De Nunzio, G.; Conte, L.; Lupo, R.; Vitale, E.; Calabrò, A.; Ercolani, M.; Carvello, M.; Arigliani, M.; Toraldo, D.M.; De Benedetto, L. A New Berlin Questionnaire Simplified by Machine Learning Techniques in a Population of Italian Healthcare Workers to Highlight the Suspicion of Obstructive Sleep Apnea. Front Med. 2022, 9, 866822. [Google Scholar] [CrossRef]
  106. Lemos, L.C.; Marqueze, E.C.; Sachi, F.; Lorenzi-Filho, G.; Moreno, C.R. Obstructive sleep apnea syndrome in truck drivers. J. Bras. Pneumol. 2009, 35(6), 500–6. [Google Scholar] [CrossRef]
  107. Argel, M.; Cunha, Â.; Conceição, M.; Abrantes, T.; Torres, A.S. Screening for Obstructive Sleep Apnea in truck drivers. Cien Saude Colet. 2023, 28(6), 1863–1872. [Google Scholar] [CrossRef]
  108. Braeckman, L.; Verpraet, R.; Van Risseghem, M.; Pevernagie, D.; De Bacquer, D. Prevalence and correlates of poor sleep quality and daytime sleepiness in Belgian truck drivers. Chronobiol. Int. 2011, 28(2), 126–34. [Google Scholar] [CrossRef]
  109. Msaad, S.; Kammoun, N.; Gargouri, R.; Khemakhem, R.; Triki, A.; Abid, N.; Fehri, S.; Kallel, K.; Kammoun, R.; Douik El Gharbi, L.; MaalejBellaj, S.; Bouhamed, H.; Abdelghani, A.; Aichaouia, C.; Turki, M.; Kammoun, S. Screening and Management of Obstructive Sleep Apnea and Daytime Sleepiness Among Professional Drivers in Tunisia: Protocol for a Machine Learning Study. JMIR Res. Protoc. 2025, 14, e70441. [Google Scholar] [CrossRef]
  110. Moreno, C.R.; Carvalho, F.A.; Lorenzi, C.; Matuzaki, L.S.; Prezotti, S.; Bighetti, P.; Louzada, F.M.; Lorenzi-Filho, G. High risk for obstructive sleep apnea in truck drivers estimated by the Berlin questionnaire: prevalence and associated factors. Chronobiol. Int. 2004, 21(6), 871–9. [Google Scholar] [CrossRef]
  111. Alahmari, M.D.; Alanazi, T.M.; Batawi, A.A.; Al-Osaimi, E.A.; Alrabeeah, S.; Jebakumar, Z.; Olaish, A.H.; Almeneessier, A.S.; BaHammam, A.S. Sleepy driving and risk of obstructive sleep apnea among truck drivers in Saudi Arabia. Traffic Inj. Prev. 2019, 20(5), 498–503. [Google Scholar] [CrossRef]
  112. Sunwoo, J.S.; Shin, D.S.; Hwangbo, Y.; Kim, W.J.; Chu, M.K.; Yun, C.H.; Jang, T.; Yang, K.I. High risk of obstructive sleep apnea, insomnia, and daytime sleepiness among commercial motor vehicle drivers. Sleep Breath 2019, 23(3), 979–985. [Google Scholar] [CrossRef]
  113. Sharwood, L.N.; Elkington, J.; Stevenson, M.; Grunstein, R.R.; Meuleners, L.; Ivers, R.Q.; Haworth, N.; Norton, R.; Wong, K.K. Assessing sleepiness and sleep disorders in Australian long-distance commercial vehicle drivers: self-report versus an "at home" monitoring device. Sleep Erratum in: Sleep. 2013;36(3):449. 2012, 35(4), 469–75. [Google Scholar] [CrossRef]
  114. Adeoti, A.O.; Desalu, O.O.; Fadare, J.O.; Elebiyo, T.; Faramade, A.A. Association Between Obstructive Sleep Apnoea, Excessive Daytime Sleepiness, and Road Traffic Accidents Among Nigerian Truck Drivers. West Afr. J. Med. 2025, 42(9), 747–754. [Google Scholar]
  115. Guglielmi, O.; Magnavita, N.; Garbarino, S. Sleep quality, obstructive sleep apnea, and psychological distress in truck drivers: a cross-sectional study. Soc. Psychiatry Psychiatr. Epidemiol. 2018, 53(5), 531–536. [Google Scholar] [CrossRef]
  116. Schwartz, D.A.; Vinnikov, D.; Blanc, P.D. Occupation and Obstructive Sleep Apnea: A Meta-Analysis. J. Occup. Environ. Med. Erratum in: J Occup Environ Med. 2018;60(1):e74. doi: 10.1097/JOM.0000000000001219. 2017, 59(6), 502–508. [Google Scholar] [CrossRef]
  117. Koyama, R.G.; Esteves, A.M.; Oliveira e Silva, L.; Lira, F.S.; Bittencourt, L.R.; Tufik, S.; de Mello, M.T. Prevalence of and risk factors for obstructive sleep apnea syndrome in Brazilian railroad workers. Sleep Med. 2012, 13(8), 1028–32. [Google Scholar] [CrossRef]
  118. Alhejaili, F.; Hafez, A.; Wali, S.; Alshumrani, R.; Alzehairi, A.M.; Balkhyour, M.; Pandi-Perumal, S.R. Prevalence of Obstructive Sleep Apnea Among Saudi Pilots. Nat. Sci. Sleep 2021, 13, 537–545. [Google Scholar] [CrossRef]
  119. Han, S.H.; Lee, G.Y.; Hyun, W.; Kim, Y.; Jang, J.S. Obstructive sleep apnea in airline pilots during daytime sleep following overnight flights. J. Sleep Res. 2021, 30(6), e13375. [Google Scholar] [CrossRef]
  120. Spiteri, G.; Arshad, M.; Rita, C.M.; Ruiu, R.; Porru, S.; Verlato, G. Risk of obstructive sleep apnea among healthcare workers: a systematic review and meta-analysis. Sci. Rep. 2026, 16(1), 26382. [Google Scholar] [CrossRef]
  121. Alharbi, S.M.; Alanazi, A.A.; Alamri, A.S.; Alaluan, H.F.; Alhuways, W.A.; Suwayid, R.K.; Almeneessier, A.S. Obstructive Sleep Apnea: Prevalence, Risk Factors, and Impact on the Academic Performance of Medical Students at a Saudi Arabian University. Saudi J. Med. Med. Sci. 2025, 13(1), 61–67. [Google Scholar] [CrossRef]
  122. Rutagarama, O.; Gelaye, B.; Tadesse, M.G.; Lemma, S.; Berhane, Y.; Williams, M.A. Risk of Common Mental Disorders in Relation to Symptoms of Obstructive Sleep Apnea Syndrome among Ethiopian College Students. J. Sleep Disord. Treat. Care 2015, 4(3). [Google Scholar] [CrossRef]
  123. Liu, W.N.; Lin, K.H.; Tsai, K.Z.; Chu, C.C.; Chang, Y.C.; Kwon, Y.; Lin, G.M. High risk for obstructive sleep apnea and risk of hypertension in military personnel: The CHIEF sleep study. World J. Clin. Cases 2023, 11(30), 7309–7317. [Google Scholar] [CrossRef]
  124. Mysliwiec, V.; Brock, M.S.; Pruiksma, K.E.; Straud, C.L.; Taylor, D.J.; Hansen, S.; Foster, S.N.; Mithani, S.; Zwetzig, S.; Gerwell, K.; Young-McCaughan, S.; Powell, T.; Blue Star, J.A.; Cassidy, D.G.; Mintz, J.; Peterson, A.L. A comprehensive evaluation of insomnia, obstructive sleep apnea and comorbid insomnia and obstructive sleep apnea in US military personnel. Sleep 2022, 45(12), zsac203. [Google Scholar] [CrossRef]
  125. Peters, J.; Shepherd, J.; Maund, E.; Grigore, B.; Woods, L.; Lord, J.; Scott, D.A.; Hyde, C. Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome - a systematic review and economic evaluation. Health Technol. Assess. 2026, 30(65), 1–242. [Google Scholar] [CrossRef]
  126. Jaganathan, N.; Goel, V.; Liu, X.; Song, W.; Kwon, Y.; Logan, J.; Healy, W.J. Individualized Treatment Approaches for Obstructive Sleep Apnea in Older Adults: Beyond Continuous Positive Airway Pressure. Adv. Geriatr. Med. Res. 2026, 8(3), e260020. [Google Scholar] [CrossRef]
  127. Magnavita, N.; Isolani, L.; De Benedetto, M.; Garbarino, S.; Gasparini, G.; Sanna, A.; Di Michele, L. Residual sleepiness during treatment of obstructive sleep apnea: occupational implications. GIPMEL G. Ital. Psicol. Med. Lav. 2025, 5(4), 293–301. [Google Scholar] [CrossRef]
  128. Morinaga, Y.; Matsumura, K.; Kansui, Y.; Sakata, S.; Goto, K.; Haga, Y.; Oishi, E.; Seki, T.; Ohtsubo, T.; Kitazono, T. Impact of obstructive sleep apnea on blood pressure and cardiovascular risk factors in Japanese men: A cross-sectional study in work-site group. Clin. Exp. Hypertens. 2018, 40(1), 73–78. [Google Scholar] [CrossRef]
  129. Eyvazlou, M.; Hosseinpouri, M.; Mokarami, H.; Gharibi, V.; Jahangiri, M.; Cousins, R.; Nikbakht, H.A.; Barkhordari, A. Prediction of metabolic syndrome based on sleep and work-related risk factors using an artificial neural network. BMC Endocr. Disord. 2020, 20(1), 169. [Google Scholar] [CrossRef]
  130. Richter, K.; Baumgärtner, L.; Niklewski, G.; Peter, L.; Köck, M.; Kellner, S.; Hillemacher, T.; Büttner-Teleaga, A. Sleep disorders in migrants and refugees: a systematic review with implications for personalized medical approach. EPMA J. 2020, 11(2), 251–260. [Google Scholar] [CrossRef]
  131. Pejovic, S.; Vgontzas, A.N.; Fernandez-Mendoza, J.; He, F.; Li, Y.; Bixler, E.O. Effect of age on the association of obstructive sleep apnea with metabolic syndrome among obese and nonobese adults. J. Clin. Sleep Med. 2025, 21(8), 1371–1378. [Google Scholar] [CrossRef]
  132. Kataoka, K.; Dohi, T.; Kasai, T.; Takaya, H.; Kasagi, S.; Tomita, Y.; Naito, R.; Narui, K. Effects of age on association between obstructive sleep apnea and metabolic syndrome in the Japanese patient population. Sleep Biol. Rhythm. 2026, 24(4), 503–510. [Google Scholar] [CrossRef]
  133. Mazzuca, E.; Battaglia, S.; Marrone, O.; Marotta, A.M.; Castrogiovanni, A.; Esquinas, C.; Barcelò, A.; Barbé, F.; Bonsignore, M.R. Gender-specific anthropometric markers of adiposity, metabolic syndrome and visceral adiposity index (VAI) in patients with obstructive sleep apnea. J. Sleep Res. 2014, 23(1), 13–21. [Google Scholar] [CrossRef]
  134. Olalere, O.; Koh, M.D.; Crabb, K.; Ajijola, O.; Tariq, S.; Tay, C.T.; Mousa, A.; Sobhy, S.; Robinson, L.; Dhillon-Smith, R.; Hoeger, K.; Moran, L.; Teede, H.; Thangaratinam, S. The effect of lifestyle interventions in women with polyendocrine metabolic ovarian syndrome: A systematic review and meta-analysis. PLoS Med. 2026, 23(9), e1004887. [Google Scholar] [CrossRef]
  135. My, T.T.; Watthayu, N. Effectiveness of non-pharmacological interventions on metabolic control in adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Diabetes Res. Clin. Pract. 2026, 241, 113556. [Google Scholar] [CrossRef]
  136. OSH Pulse 2025: Occupational safety and health in the era of climate and digital change. 23 9 2025. Available online: https://osha.europa.eu/en/publications/summary-osh-pulse-2025-occupational-safety-and-health-era-climate-and-digital-change (accessed on 18 October 2026).
  137. Liu, H.; Wang, X.; Feng, H.; Zhou, S.; Pan, J.; Ouyang, C.; Hu, X. Obstructive sleep apnea and mental disorders: a bidirectional mendelian randomization study. BMC Psychiatry 2024, 24(1), 304. [Google Scholar] [CrossRef]
  138. Sommerhoff, C.; Bort, M.; Prisco, M.; Paolucci, S.; Dalmases, M.; Oliva, V.; Vieta, E.; Murru, A.; Fico, G. The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis. Acta Psychiatr. Scand. 2026, 154(5), 322–341. [Google Scholar] [CrossRef]
  139. Zhu, F.; Cui, C.; Gu, K. Prevalence and predictors of obstructive sleep apnea in patients with bipolar disorder: A systematic review and meta-analysis. Pak. J. Med. Sci. 2025, 41(1), 302–311. [Google Scholar] [CrossRef]
  140. Pan, M.L.; Tsao, H.M.; Hsu, C.C.; Wu, K.M.; Hsu, T.S.; Wu, Y.T.; Hu, G.C. Bidirectional association between obstructive sleep apnea and depression: A population-based longitudinal study. Medicine 2016, 95(37), e4833. [Google Scholar] [CrossRef]
  141. LaGrotte, C.; Fernandez-Mendoza, J.; Calhoun, S.L.; Liao, D.; Bixler, E.O.; Vgontzas, A.N. The relative association of obstructive sleep apnea, obesity and excessive daytime sleepiness with incident depression: a longitudinal, population-based study. Int. J. Obes. (Lond) 2016, 40(9), 1397–404. [Google Scholar] [CrossRef]
  142. Hesami, Z.; Atashrooz, M.; Sardarzehi, R.; Looha, M.A.; Khorsand, B.; Houri, H. The oro- and nasopharyngeal microbiota as a revolutionary perspective on mental disorders and related psychopathology: a systematic review and meta-analysis. J. Transl. Med. 2025, 23(1), 726. [Google Scholar] [CrossRef]
  143. Etindele Sosso, F.A.; Kreidlmayer, M.; Pearson, D.; Bendaoud, I. Towards A Socioeconomic Model of Sleep Health among the Canadian Population: A Systematic Review of the Relationship between Age, Income, Employment, Education, Social Class, Socioeconomic Status and Sleep Disparities. Eur. J. Investig. Health Psychol. Educ. 2022, 12(8), 1143–1167. [Google Scholar] [CrossRef]
  144. Donato, K.O.; Andrade Fernandes, J.V.; Pereira, M.A.; Oliveira DA Silva, R.; Romeo, B.S.; Braga DE Souza, G.A.; Cunha, L.M.C.; Donato, A.O.; DE Jesus, K.C.O.; Salles, C.; Nova Aguiar, C.V. Co-occurrence of sleep disturbances and perceived stress in law enforcement personnel: a systematic review and meta-analysis. Minerva Med. 2026, 117(4), 223–230. [Google Scholar] [CrossRef]
  145. Johnston, B.; Wynne, D.; Threlfall, M.; Gardner, K.; Campodonico, C. A systematic review of the prevalence, risk factors, and protective factors of posttraumatic stress disorder among paramedics. J. Trauma Stress. 2026, 39(5), 745–760. [Google Scholar] [CrossRef]
  146. Ye, X.; Huang, C.; Zhou, J.; Qiu, Z.; Wu, J.; Wu, H.; Mo, L. Long-term night shift work and cardiometabolic health in healthcare workers: a review of mechanisms and precision intervention strategies. Front Public Health 2026, 14, 1934083. [Google Scholar] [CrossRef]
  147. Ko, H.; Cho, S.S.; Lee, H.E.; Min, J.; Kang, M.Y. Work-related risk factors of sleep apnea: evidence from the Korean work, sleep, and health study. Int. Arch. Occup. Environ. Health 2025, 98(9-10), 797–805. [Google Scholar] [CrossRef]
  148. Magnavita, N.; Garbarino, S. Sleep, Health and Wellness at Work: A Scoping Review. Int. J. Environ. Res. Public Health 2017, 14(11), pii: E1347. [Google Scholar] [CrossRef]
  149. Salari, N.; Gholami, A.; Jalili, F.; Zereshki, E.; Heidarian, P.; Shohaimi, S.; Mohammadi, M. Global Prevalence of Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. Indian J. Otolaryngol. Head Neck Surg. 2025, 77(1), 216–223. [Google Scholar] [CrossRef]
  150. Gold, M.S.; Stoohs, R.A.; Gold, A.R. Objective versus subjective excessive daytime sleepiness in OSA: Quantifying the impact of fatigue. Sleep Med. 2026, 142, 108867. [Google Scholar] [CrossRef]
  151. Morris, J.L.; Baniak, L.M.; Asadollah, F.; Imes, C.C.; Orbell, S.; Garbioglu, P.; Scott, P.W.; Wimms, A.; Luyster, F.S. What do we know about the Epworth Sleepiness Scale in women? A review of the evidence. Sleep Med. Rev. 2026, 89, 102323. [Google Scholar] [CrossRef]
  152. Wada, H.; Nakano, H.; Sakurai, S.; Tanigawa, T. Self-reported sleep tendency poorly predicts the presence of obstructive sleep apnea in commercial truck drivers. Sleep Med. 2024, 115, 109–113. [Google Scholar] [CrossRef] [PubMed]
  153. Baiardi, S.; La Morgia, C.; Sciamanna, L.; Gerosa, A.; Cirignotta, F.; Mondini, S. Is the Epworth Sleepiness Scale a useful tool for screening excessive daytime sleepiness in commercial drivers? Accid. Anal. Prev. 2018, 110, 187–189. [Google Scholar] [CrossRef]
Table 1. Normality analysis of continuous variables. Anderson-Darling test.
Table 1. Normality analysis of continuous variables. Anderson-Darling test.
Variable n Mean s.d. Median min max Skewness Kurtosis Anderson
Age 2226 47.605 9.376 48 19 75 -0.441 0.036 7.506
Work Annoyance (WAS) 2226 39.422 18.551 40 0 90 0.021 -0.402 1.404
Effort 2214 8.247 2.298 8 3 12 -0.222 -0.541 22.389
Reward 2214 17.481 3.820 18 7 28 -0.008 -0.182 6.443
Stress (ERI) 2214 1.189 0.521 1.098 0.25 4.0 1.002 1.731 22.600
Overcommitment 2214 13.889 3.703 14 6 24 0.269 -0.121 11.291
Social support 2222 19.214 3.369 19 6 24 -0.745 0.611 25.487
Sleep quality (PSQI) 2226 5.626 3.443 5 0 20 0.783 0.615 28.249
Sleepiness (ESS) 2226 5.851 4.153 5 0 24 0.935 0.826 34.555
Mental problems (GHQ12) 2226 12.008 5.783 11 0 36 1.023 1.077 51.221
Age 2226 47.605 9.376 48 19 75 -0.441 0.036 7.506
Table 2. Work-related and mental health variables. Comparison between workers with suspected OSA and their colleagues.
Table 2. Work-related and mental health variables. Comparison between workers with suspected OSA and their colleagues.
Variable High risk of OSA Other workers p1 Cohen’s D
Work Annoyance (WAS) 44.57±19.32 38.47±18.25 <0.001 -0.331(-0.446; -0.216)
Stress (ERI) 1.36±0.57 1.16±0.51 <0.001 -0.396 (-0.511; -0.281)
Overcommitment 15.39±3.91 13.63±3.67 <0.001 -0.475 (-0.590; -0.360)
Social support 18.21±3.85 19.40±3.24 <0.001 0.357 (0.242; 0.472)
Job satisfaction 4.12±1.60 4.60±1.46 <0.001 0.324 (0.207; 0.441)
Work ability 7.64±2.30 8.58±1.74 <0.001 0.510 (0.394; 0.625)
Sleep quality (PSQI) 7.85±3.59 5.21±3.25 <0.001 -0.796 (-0.913; -0.679)
Sleepiness (ESS) 6.98±4.51 5.64±4.05 <0.001 -0.324 (-0.439; -0.210)
Mental problems (GHQ12) 14.98±6.51 11.46±5.47 <0.001 -0.624 (-0.740; -0.508)
Happiness 6.30±2.03 7.09±1.80 <0.001 0.430 (0.313; 0.547)
1 Student t test.
Table 3. Cardiovascular risk factor. Comparison between workers with suspected OSA and their colleagues.
Table 3. Cardiovascular risk factor. Comparison between workers with suspected OSA and their colleagues.
Disorder High risk of OSA Other workers p1
Hypertension 194 (55.7%) 234 (12.5%) <0.001
Hypercholesterolemia 165 (47.3%) 511 (27.2%) <0.001
Hypertriglyceridemia 84 (24.1%) 197 (10.5%) <0.001
Hyperglycemia 56 (16.1%) 95 (5.1%) <0.001
Obesity 255 (73.3%) 645 (34.3%) <0.001
Metabolic syndrome 124 (35.6%) 171 (9.1%) <0.001
1 chi square.
Table 4. Occupational, domestic, and driving accidents. Comparison between workers with suspected OSA and their colleagues.
Table 4. Occupational, domestic, and driving accidents. Comparison between workers with suspected OSA and their colleagues.
Type of injury High OSA risk Other workers p1
Work injury 48 (13.8%) 119 (6.3%) <0.001
Home injury 61 (17.5%) 203 (10.8%) <0.001
Driving accident 33 (9.5%) 144 (7.7%) 0.250
Near-miss driving accident 126 (36.2%) 440 (23.4%) <0.001
Falling asleep while driving 76 (21.8%) 223 (11.9%) <0.001
1 chi square.
Table 5. Bivariate correlation between HRO, work-related and health-related variables. Pearson’s r (lower triangle) and Spearman’s rho (upper triangle).
Table 5. Bivariate correlation between HRO, work-related and health-related variables. Pearson’s r (lower triangle) and Spearman’s rho (upper triangle).
HRO Sex (female) eAge Annoyance ERI Overcom Support PSQI Sleepiness Ability Satisfaction Happiness Distress
HRO 1 -0.088** 0.152** 0.117** 0.138** 0.170** -0.106** 0.266** 0.111** -0.170** -0.112** -0.148** 0.214**
Sex (female) -0.088** 1 -0.114** 0.110** 0.013 0.085** -0.008 0.056** 0.037 0.000 0.030 -0.058** 0.084**
Age 0.147** -0.105** 1 0.184** 0.080** 0.104** -0.099** 0.101** -0.074** -0.069** -0.112** -0.138** 0.090**
Annoyance 0.120** 0.111** 0.192** 1 0.300** 0.266** -0.285** 0.316** 0.213** -0.265** -0.241** -0.237** 0.403**
ERI 0.143** 0.012 0.088** 0.276** 1 0.512** -0.489** 0.323** 0.164** -0.171** -0.352** -0.265** 0.447**
Overcom 0.170** 0.096** 0.092** 0.265** 0.507** 1 -0.330** 0.390** 0.149** -0.176** -0.278** -0.346** 0.509**
Support -0.129** 0.014 -0.108** -0.278** -0.484** -0.337** 1 -0.262** -0.140** 0.144** 0.319** 0.230** -0.366**
PSQI 0.278** 0.056** 0.112** 0.325** 0.302** 0.394** -0.246** 1 0.222** -0.223** -0.242** -0.395** 0.542**
Sleepiness 0.117** 0.033 -0.052* 0.216** 0.169** 0.158** -0.143** 0.217** 1 -0.144** -0.115** -0.145** 0.253**
Ability -0.182** 0.017 -0.053* -0.192** -0.174** -0.146** 0.136** -0.211** -0.120** 1 0.154** 0.274** -0.282**
Satisfaction -0.117** 0.041 -0.118** -0.201** -0.373** -0.276** 0.318** -0.219** -0.112** 0.151** 1 0.281** -0.358**
Happiness -0.154** -0.069** -0.133** -0.226** -0.266** -0.344** 0.249** -0.412** -0.149** 0.253** 0.273** 1 -0.519**
Distress 0.221** 0.093** 0.087** 0.381** 0.434** 0.494** -0.360** 0.558** 0.261** -0.255** -0.345** -0.535** 1
Note: * p <0.05; ** p<0.01.
Table 6. Hierarchical multiple logistic regression. Prediction models for mental disorders, defined as GHQ12>11.
Table 6. Hierarchical multiple logistic regression. Prediction models for mental disorders, defined as GHQ12>11.
Model I1 Model II2 Model III3 Model IV4
Variable OR (CI95%) p OR (CI95%) p OR (CI95%) p OR (CI95%) p
HRO 3.147 (2.461; 4.025) <0.001 2.094 (1.554; 2.822) <0.001 1.410 (1.022; 1.946) 0.036 1.500 (1.067; 2.107) 0.019
Gender (female) 1.588 (1.313; 1.919) <0.001 1.260 (1.001; 1.585) 0.049 1.151 (0.902; 1.468) 0.258 1.045 (0.810; 1.348) 0.736
Age 1.014 (1.004; 1.023) 0.005 0.991 (0.979; 1.002) 0.109 0.994 (0.982; 1.006) 0.322 0.988 (0.975; 1.001) 0.062
Annoyance 1.030 (1.023; 1.036) <0.001 1.023 (1.016; 1.030) <0.001 1.023 (1.015; 1.030) <0.001
Stress (ERI) 1.478 (1.136; 1.923) 0.004 1.376 (1.043; 1.815) 0.024 1.508 (1.125; 2.021) 0.006
Overcommitment 1.237 (1.194; 1.282) <0.001 1.190 (1.146; 1.235) <0.001 1.161 (1.116; 1.208) <0.001
Social support 0.930 (0.897; 0.965) <0.001 0.934 (0.899; 0.970) <0.001 0.946 (0.909; 0.986) 0.008
Job satisfaction 0.859 (0.796; 0.928) <0.001 0.873 (0.804; 0.948) 0.001 0.917 (0.839; 1.003) 0.057
Work ability 0.880 (0.831; 0.932) <0.001 0.913 (0.859; 0.970) 0.004 0.952 (0.890; 1.018) 0.153
Sleep quality 1.290 (1.239; 1.343) <0.001 1.257 (1.204; 1.312) <0.001
Sleepiness 1.073(1.043; 1.104) <0.001 1.075 (1.043; 1.108) <0.001
Happiness 0.653 (0.604; 0.706) <0.001
Nagelkerke R2 0.070 0.394 0.484 0.539
1 Model I: Adjusted for age and gender; 2 Model II. Additionally adjusted for annoyance, stress, overcommitment, social support, job satisfaction, and work ability; 3 Model III: additionally adjusted for sleep quality and sleepiness; 4 Model IV: additionally adjusted for happiness.
Table 7. Hierarchical multiple logistic regression. Prediction models for metabolic syndrome.
Table 7. Hierarchical multiple logistic regression. Prediction models for metabolic syndrome.
Model I1 Model II2 Model III3 Model IV4
Variable OR (CI95%) p OR (CI95%) p OR (CI95%) p OR (CI95%) p
HRO 4.741 (3.599; 6.246) <0.001 4.986 (3.712; 6.697) <0.001 4.896 (3.613; 6.634) <0.001 4.683 (3.447; 6.362) <0.001
Gender (female) 0.651 (0.500; 0.848) 0.001 0.662 (0.502; 0.873) 0.003 0.658 (0.499; 0.868) 0.003 0.564 (0.420; 0.757) <0.001
Age 1.047 (1.030;1.063) <0.001 1.047 (1.030; 1.064) <0.001 1.046 (1.029; 1.063) <0.001 1.046 (1.029; 1.063) <0.001
Annoyance 1.000 (0.992; 1.008) 0.993 1.000 (0.992; 1.008) 0.934 1.000 (0.992; 1.008) 0.994
Stress (ERI) 1.505 (1.099; 2.061) 0.011 1.508 (1.100; 2.066) 0.011 1.479 (1-078;2.029) 0.015
Overcommitment 0.984 (0.944; 1.025) 0.439 0.980 (0.940; 1.023) 0.361 0.986 (0.945; 1.028) 0.503
Social support 1.049 (1.003; 1.098) 0.038 1.050 (1.003; 1.098) 0.036 1.050 (1.003; 1.099) 0.036
Job satisfaction 1.007 (0.913; 1.109) 0.895 1.008 (0.915; 1.112) 0.868 1.016 (0.921; 1.122) 0.749
Work ability 0.985 (0.920; 1.056) 0.679 0.987 (0.921; 1.059) 0.722 0.989 (0.921; 1.062) 0.766
Sleep quality 1.017 (0.973; 1.062) 0.467 1.011 (0.967; 1.057) 0.624
Sleepiness 0.992 (0.960; 1.026) 0.652 0.995 (0.962; 1.028) 0.755
Smoke 1.046 (0.936; 1.169) 0.432
Sedentary lifestyle 1.201 (1.057; 1.366) 0.005
Diet 0.931 (0.808; 1.072) 0.320
Alcohol 0.765 (0.603; 0.972) 0.028
Nagelkerke R2 0.153 0.164 0.165 0.176
1 Model I: Adjusted for age and gender; 2 Model II. Additionally adjusted for annoyance, stress, overcommitment, social support, job satisfaction, and work ability; 3 Model III: additionally adjusted for sleep quality and sleepiness; 4 Model IV: additionally adjusted for smoke, physical activity, diet control, alcohol.
Table 8. Hierarchical multiple logistic regression. Prediction models for home, work, and driving accidents.
Table 8. Hierarchical multiple logistic regression. Prediction models for home, work, and driving accidents.
Model I1 Model II2 Model III3 Model IV4
Variable OR (CI95%) p OR (CI95%) p OR (CI95%) p OR (CI95%) p
HRO 1.759 (1.360; 2.274) <0.001 1.421 (1.081; 1.868) 0.012 1.222 (0.922; 1.620) 0.163 1.288 (0.969; 1.713) 0.081
Gender (female) 1.350 (1.081; 1.685) 0.008 1.238 (0.981; 1.563) 0.072 1.211 (0.957; 1.531) 0.111 1.181 (0.922; 1.514) 0.188
Age 1.004 (0.933;1.015) 0.468 0.999 (0.987; 1.011) 0.835 1.000 (0.988; 1.012) 0.961 1.001 (0.989; 1.013) 0.884
Annoyance 1.006 (0.999; 1.012) 0.072 1.002 (0.995; 1.008) 0.600 1.001 (0.995; 1.008) 0.704
Stress (ERI) 1.512 (1.187; 1.928) <0.001 1.478 (1.157; 1.888) 0.002 1.442 (1.124; 1.851) 0.004
Overcommitment 1.035 (1.003; 1.069) 0.031 1.014 (0.982; 1.048) 0.392 1.011 (0.977; 1.046) 0.539
Social support 0.991 (0.957; 1.026) 0.610 0.995 (0.960; 1.032) 0.800 1.000 (0.964; 1.037) 0.991
Job satisfaction 0.975 (0.903; 1.052) 0.511 0.987 (0.913; 1.067) 0.735 1.002 (0.924; 1.086) 0.968
Work ability 0.950 (0.900; 1.004) 0.068 0.966 (0.913; 1.022) 0.225 0.970 (0.916; 1.029) 0.313
Sleep quality 1.078 (1.042; 1.116) <0.001 1.098 (1.028; 1.109) <0.001
Sleepiness 1.035 (1.010; 1.062) 0.007 1.031 (1.005; 1.058) 0.020
Mental health 1.017 (0.991; 1.043) 0.205
Happiness 0.992 (0.927; 1.062) 0.812
Smoke 1.042 (0.955; 1.137) 0.353
Sedentary lifestyle 0.953 (0.865; 1.049) 0.322
Diet 0.984 (0.879; 1.100) 0.771
Alcohol 1.024 (0.851; 1.231) 0.805
Nagelkerke R2 0.017 0.060 0.080 0.083
1 Model I: Adjusted for age and gender; 2 Model II. Additionally adjusted for annoyance, stress, overcommitment, social support, job satisfaction, and work ability; 3 Model III: additionally adjusted for sleep quality and sleepiness; 4 Model IV: additionally adjusted for mental health, happiness, smoke, physical activity, diet control, alcohol.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.